Curis Correlations
CRIS Stock | USD 4.39 0.06 1.35% |
The current 90-days correlation between Curis Inc and Aileron Therapeutics is 0.06 (i.e., Significant diversification). The correlation of Curis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Curis Correlation With Market
Average diversification
The correlation between Curis Inc and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Curis Inc and DJI in the same portfolio, assuming nothing else is changed.
Curis |
Moving together with Curis Stock
0.84 | HLN | Haleon plc | PairCorr |
0.86 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.89 | LLY | Eli Lilly | PairCorr |
0.9 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.87 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.87 | RDY | Dr Reddys Laboratories | PairCorr |
0.82 | TAK | Takeda Pharmaceutical | PairCorr |
0.84 | ZTS | Zoetis Inc | PairCorr |
0.73 | LTRN | Lantern Pharma | PairCorr |
0.8 | AMGN | Amgen Inc | PairCorr |
0.74 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.83 | ANRO | Alto Neuroscience, | PairCorr |
Moving against Curis Stock
0.82 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.71 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.67 | GILD | Gilead Sciences | PairCorr |
0.66 | VTRS | Viatris | PairCorr |
0.59 | WAT | Waters | PairCorr |
0.55 | EBS | Emergent Biosolutions | PairCorr |
0.51 | EWTX | Edgewise Therapeutics | PairCorr |
0.48 | BHC | Bausch Health Companies | PairCorr |
0.66 | MNMD | Mind Medicine | PairCorr |
0.65 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
0.55 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
0.54 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.4 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
0.37 | NBIX | Neurocrine Biosciences | PairCorr |
0.31 | MOLN | Molecular Partners | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Curis Stock performing well and Curis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Curis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ALRN | 4.31 | 0.42 | 0.06 | 2.32 | 4.65 | 8.06 | 41.47 | |||
ARTL | 3.52 | (0.31) | 0.00 | (0.12) | 0.00 | 7.83 | 26.32 | |||
HSTO | 4.52 | (1.51) | 0.00 | (2.40) | 0.00 | 4.76 | 131.40 | |||
TMBR | 4.23 | 0.37 | 0.04 | (31.46) | 5.18 | 13.02 | 37.57 | |||
XFOR | 5.02 | (0.47) | 0.00 | (0.22) | 0.00 | 8.82 | 62.35 | |||
MREO | 2.72 | (0.48) | 0.00 | (0.30) | 0.00 | 4.80 | 17.36 | |||
INZY | 2.76 | (1.22) | 0.00 | (0.59) | 0.00 | 5.07 | 16.62 | |||
TERN | 3.37 | (0.33) | 0.00 | (0.22) | 0.00 | 6.02 | 34.09 | |||
LPTX | 3.85 | 0.07 | 0.01 | 0.21 | 4.33 | 11.08 | 25.59 | |||
DAWN | 2.06 | (0.09) | (0.04) | 0.01 | 2.77 | 3.84 | 11.44 |
Curis Corporate Management
Jonathan Zung | Chief Officer | Profile | |
Reinhard MD | Senior Development | Profile | |
Elif McDonald | VP Communications | Profile | |
Mark Noel | Vice Property | Profile |